Get my own profile
Public access
View all17 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Mikhail SavitskiEMBLVerified email at embl.de
- Isabelle BecherEMBL HeidelbergVerified email at embl.de
- André MateusAssistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)Verified email at umu.se
- Marcus BantscheffCellzome, a GSK companyVerified email at gsk.com
- Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
- Holger FrankenGSKVerified email at holgerfranken.de
- Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
- Nassos TypasGroup Leader, EMBLVerified email at embl.de
- Sindhuja SridharanECR (Lecturer), Blizard Institute, Barts and The London School of Medicine andVerified email at qmul.ac.uk
- Giovanna BergaminiCellzome GmbH, a GSK companyVerified email at GSK.com
- Martin BeckMax Planck Institute of BiophysicsVerified email at biophys.mpg.de
- Carl HerrmannProfessor of Bioinformatics - IPMB - Heidelberg UniversityVerified email at uni-heidelberg.de
- Bernhard KusterProfessor for Proteomics and BioanalyticsVerified email at tum.de
- Johannes F. HevlerStanford UniversityVerified email at stanford.edu
- Simon AndersBioquant Center, University of HeidelbergVerified email at fs.tum.de
- Sebastian SteinhauserNovartis Institutes for BioMedical Research - Discovery Sciences Data ScienceVerified email at novartis.com
- Natalie RomanovEMBL HeidelbergVerified email at embl.de
- Pedro BeltraoAssociate Professor, ETH ZurichVerified email at ethz.ch
- Karsten BachPostdoctoral researcher, ETH ZurichVerified email at bsse.ethz.ch
- Daniel HuebschmannClinician scientist, group leader National Center for Tumor Diseases (NCT) Heidelberg and GermanVerified email at dkfz-heidelberg.de